GlaxoSmithKline today released Unaudited Interim Financial Statements for the three months ended 31 March 2017.
Revenue N’million
Q1 2017| N3,850
Q1 2016| N4,152
%age change|-7%
(Loss)/Profit after tax N’million
Q1 2017| N-8
Q1 2016| N116
%age change| N/A
EPS (Kobo)
Q1 2017|-1k
Q1 2016|10k
%age change|N/A%
Nairametrics
Nairametrics is Nigeria’s top business news and financial analysis website. We focus on providing resources that help small businesses and retail investors make better investing decisions. Nairametrics is updated daily by a team of professionals. Post updated as “Nairametrics” are published by our Editorial Board.